Synonyms
|
- CARDIO IQ ADVANCED LIPID PANEL
- CARDIOIQ
- LAB10867
|
Cerner Name
|
Cardio IQ Advanced Lipid Panel
|
Clinical Info
|
The advanced lipid profile provides a more comprehensive assessment of dyslipidemia and cardiovascular risk than standard
lipid panel measurements
|
Specimen Sources
|
Blood, Arterial
Blood, Capillary
Blood, Central Line
Blood, Venous
|
Specimen Types
|
Blood
|
Specimen Volume
|
4 mL serum (2 ml min)
|
Container
|
Gold Top Tube
|
Collection Instructions
|
Container/Tube: Gold top tube
Specimen: 4 mL serum (2 ml min)
Collection Instructions
The assay manufacturer Beckman Coulter advises: "N-Acetyl Cysteine (NAC), when administered in therapeutic concentrations (for the treatment of acetaminophen overdose), has been...determined to interfere with assays for... Cholesterol, Uric Acid" where "NAC interference may lead to falsely low results." According to Beckman Coulter, the NAC interference should be insignificant by 12 hours after completion of the initial loading dose of an IV infusion treatment regimen consisting of an initial loading dose of 150 mg/kg administered over 1 hour, a second dose of 50 mg/kg administered over 4 hours and a third dose of 100 mg/kg administered over 16 hours.
Patient Preparation
If a Cholesterol measurement is to be performed along with Triglycerides, but not part of a Lipid Panel, then the patient should be fasting 9-12 hours prior to collection. If the Cholesterol is ordered as part of a Lipid Panel, then a fasting sample is not required.
|
Transport Instructions
|
Refrigerated
|
Specimen Stability
|
Room temperature: 24 hours
Refrigerated: 7 days
Frozen: 15 days
|
Methodology
|
Enzymatic • Nephelometry • Immunoturbidometric • Ion Mobility • Spectrophotometry (SP)
Includes:
Cardio IQ® Cholesterol, Total; Cardio IQ® HDL Cholesterol; Cardio IQ® Triglycerides; Cardio IQ® Non-HDL and Calculated Components; Cardio IQ® Lipoprotein Fractionation, Ion Mobility; Cardio IQ® Apolipoprotein B; Cardio IQ® Lipoprotein (a)
If Triglyceride is >400 mg/dL, then Cardio IQ® Direct LDL will be performed at an additional charge
|
Days Performed
|
Monday - Friday
TAT: 5 - 8 Days
|
Performing Laboratories
|
Quest Diagnostics' Nichols Institute, Inc. - Chantilly
|
CPT
|
82172,82465,83695,83704,83718,84478
|
PDM
|
1759390
|
Results
|
| Component Name |
Base Name |
Common Name |
External Name |
| LDL CALCULATED |
LDLCALC |
LDL CALC |
LDL Cholesterol (Calc) |
| CHOLESTEROL/HDL RATIO |
CHOLHDL |
CHOLESTEROL HDL RATIO |
Cholesterol/HDL Ratio |
| LDL PARTICLE NUMBER |
LDLPARTNUM |
LDL PARTICLE NUMBER |
LDL Particle Number |
| LDL SMALL |
LDLSML |
LDL SMALL |
LDL Small |
| LDL MEDIUM |
LDLMED |
LDL MEDIUM |
LDL Medium |
| HDL LARGE |
HDLL |
HDL LARGE |
HDL Large |
| LDL PATTERN |
LDLPAT |
LDL PATTERN |
LDL Pattern |
| LDL PEAK SIZE |
LDLPKSZ |
LDL PEAK SIZE |
LDL Peak Size |
| CHOLESTEROL, TOTAL RESULT |
CHOL |
CHOLESTEROL, TOTAL RESULT |
Cholesterol, Total |
| HDL CHOLESTEROL, SERUM |
HDL |
HDL |
HDL Cholesterol |
| TRIGLYCERIDES RESULT |
TRIG |
TRIGLYCERIDES |
Triglycerides |
| NON-HDL CHOLESTEROL |
LDL |
NON HDL CHOL LDL VLDL |
Non-HDL Cholesterol |
| APOLIPOPROTEIN B RESULT |
APOLIPOB |
APOLIPOPROTEIN B RESULT |
Apolipoprotein B |
| LIPOPROTEIN (A) |
LIPOA |
LIPOPROTEIN A |
Lipoprotein (a) |
|
Result Interpretation
See Laboratory Report
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics.
It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and
is used for clinical purposes.
|
Forms
|
|
